Tuesday - June 9, 2026
UC Expert Weighs in on Current MASH Treatment Approaches
June 06, 2026
CINCINNATI, Ohio, June 6 -- The University of Cincinnati posted the following news:

* * *

UC expert weighs in on current MASH treatment approaches

He says pharmacotherapy pipeline is rapidly evolving

By Megan Burgasser, burgasma@ucmail.uc.edu

As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products